Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03650673
Other study ID # 7414
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date July 15, 2019
Est. completion date October 31, 2024

Study information

Verified date September 2023
Source University Hospital, Montpellier
Contact Yves-Marie PERS, MD
Phone +33 618993804
Email ympers2000@yahoo.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The late-stage forms of degenerative osteoarthritis (OA) are very debilitating and less affordable to therapy. The main objective is to identify early onset symptoms of hand OA patients through imaging techniques (such as ultrasound and MRI). Our primary endpoint is to specify patients with high risk of radiological profression (X-ray).


Recruitment information / eligibility

Status Recruiting
Enrollment 150
Est. completion date October 31, 2024
Est. primary completion date July 31, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - Early digital osteoarthritis must combine the clinical AND radiological definition. Clinical definition: At least one of the following 4 criteria: Pain or stiffness or swelling or deformity of a digital joint (IPP and / or IPD) A breach of at least one PPI and / or IPD Age under 60 at the time of the first symptoms Clinical symptoms have been changing for less than 3 years Radiographic definition: The presence of the achievement of at least one PPI and / or IPD. Presence of at least two of the following three criteria: pinching, marginal subchondral condensation, marginal osteophyte Erosion on radiography is not an exclusion criteria - Consent form signed Exclusion criteria: - patients suffering from rheumatoid arthritis, rheumatoid psoriasis or any other inflammatory rheumatism - patients suffering from metabolic diseasis such as gout, hemochromatosis, Wilson's disease; or from congenital disease such as displasie, osteogenesis, - Presence of advanced radiographic osteoarthritis based in Kellgreen Lawrence score (=4) in one joint among the 10 previous sites. - Not able to provide a sample of blood for any reasons - MRI contraindication - Being in exclusion period determined by another previous study - Subject non affiliated to social insurance - Pregnant or lactating women - Vulnerable people based in L1121-5 article of CSP - Elderly subject or protected subjects disabled to give their consent - Subjects private of freedom by court or administrative order

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Identification of subgroups of patients with early AD with risk of progression
Clinical examination with questionnaires, Biological collection, Imaging (radiography, densitometry, ultrasound, and MRI)

Locations

Country Name City State
France Department of Rheumatology, CHU Montpellier Montpellier

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Radiographic progression judged by the number of joints whose KL index has evolved Evaluation of prognostic role of imaging factors in x-ray progression of early onset hand osteoarthritis 2 years
Secondary The number of painful / swollen or deformed joints in the hands. Photographs of the patients' hands will be taken at each visit. 2 years
Secondary The location of painful / swollen or deformed joints in the hands. Photographs of the patients' hands will be taken at each visit. 2 years
Secondary The intensity of pain over the last 48 hours The intensity of pain over the last 48 hours will be assessed by the patient at each visit on a visual analogue scale (VAS). EVA pain (visual analogue scale over 100 mm): one-dimensional measurement of the intensity of pain. EVA pain is a continuous scale consisting of a horizontal line from 0 (no pain) to 100 mm (maximum pain) 2 years
Secondary The activity of the disease over the last 48 hours The activity of the disease over the last 48 hours will be evaluated at each visit by the patient and the doctor on a visual analog scale from 0 (no pain) to 100 mm (maximum pain) 2 years
Secondary The aesthetic impact of osteoarthritis of the hands The aesthetic impact of osteoarthritis of the hands will be evaluated at each visit by the patient on a visual analog scale from 0 (no pain) to 100 mm (maximum pain) 2 years
Secondary The number of consumption of care in the month preceding the visit 2 years
Secondary The number of hand surgery during follow-up 56/5000 The number of a hand surgery during follow-up 2 years
Secondary The grip force measured by a dynamometer 2 years
Secondary The impact on pain and function on the hand measured by the AUSCAN questionnaire The impact on pain and function measured by the AUSCAN questionnaire. This is a functional index including 15 questions with a specific orientation to osteoarthritis of the hands, assessing pain / stiffness and function. The score varies from 0 to 60. Fill in the questionnaire: 7 min 2 years
Secondary The impact on pain and function on the hand measured by the COCHIN functional index The impact on pain and function measured by the COCHIN functional index wich is oriented towards AD. It includes 18 questions, ranging from 0 to 5, and is particularly interested in the impact of osteoarthritis of the hands on the daily activities (cooking, clothing, hygiene, office ...) of the patient. The score varies from 0 to 90. Questionnaire filling time: 5 min 2 years
Secondary The impact on pain and function on the hand measured by a 6-minute walk test The impact on pain and function measured by a 6-minute walk test that characterizes an overall assessment of functional ability to exercise. The patient is asked to walk as much as possible for 6 minutes (round trip in a 30m corridor), the pace of walking is freely chosen (ATS Recommendations, 2002) 2 years
Secondary The impact on pain and function measured the IPAQ International Physical Activity Questionnaire The short version with 7 questions will be used 2 years
Secondary The professional impact measured by the WPAI questionnaire which measures the deficiencies of paid work and unpaid work over the last 7 days The WPAI questionnaire is an instrument for measuring deficiencies in paid work and unpaid work over the last 7 days. It measures absenteeism, presenteeism as well as the deficiencies of unpaid activity due to a health problem. It contains 6 questions and has already been used during AD 2 years
Secondary Impact on quality of life measured by the Health Assessment Questionnaire (HAQ) The Health Assessment Questionnaire (HAQ) is a measure of quality of life in health. The questionnaire is designed to be completed by the patient himself, without the help of a doctor. We will use an adaptation of the HAQ, the Modified Health Assessment Questionnaire (MHAQ), as in the Kwok et al. Study, with 8 questions about the function of the hand. The score ranges from 0 to 3. The average score reported in osteoarthritis studies is 0.8. It is 0.49 in the global population. 2 years
Secondary The impact on the quality of life measured by the SF-36 questionnaire The SF-36 questionnaire assesses the quality of life. It is a validated international questionnaire. It consists of 36 items evaluating 8 dimensions. It can be used in health economics studies as a variable in the calculation of a Quality Adjusted Life Year (QALY) to determine the cost-effectiveness of a health intervention. Fill in the questionnaire: 10 min. 2 years
Secondary The impact on the quality of life measured by the EQ-5D-3L questionnaire (https://euroqol.org) This score varies between 0 and 1: 0 represents death, and 1 the best quality of life possible. So, this score indicates the decrease in quality of life compared to an optimal state of health. The more desirable a health state, the higher the score associated with it. Negative scores are possible if the subject perceives a state of health worse than death. The EQ-5D-3L includes the following five dimensions: mobility, self-care, usual activities, pain / discomfort, and anxiety / depression. Each dimension has 3 levels: absence of problems, presence of problems and extreme problems. Questionnaire filling time: 5 min 2 years
Secondary The Impact on Quality of Life Measured by the Michigan Hand Outcome Questionnaire (MHQ) It is an international questionnaire validated with 6 items, which assesses the aesthetic impact of osteoarthritis of the hands. The questionnaire includes the function of the overall hand, the activities of daily life, the pain, the work, the appearance of the hands and the satisfaction of the patient with the functionality of his hands. In the ladder pain, a high score indicates more intense pain, while in the rest of the items, a better score reveals better hand functionality. Duplicate filling time: 15 min. 2 years
Secondary The psychological impact of pain measured by the HAD questionnaire (Hospital Anxiety and Depression) This questionnaire assesses the psychological impact of the patient. It consists of 14 questions with 4 possible answers. This score makes it possible to differentiate a level of anxiety and a level of depression according to the answers. Each sub-scale varies from 0 to 21. Questionnaire filling time: 5 min 2 years
Secondary The aesthetic impact of osteoarthritis of the hands with the Michigan Hand Outcome Questionnaire The aesthetic impact of osteoarthritis of the hands will be evaluated at each visit by the patient with the help of the Michigan Hand Outcome Questionnaire. It is an international questionnaire validated with 6 items, which assesses the aesthetic impact of osteoarthritis of the hands. The questionnaire includes the function of the overall hand, the activities of daily life, the pain, the work, the appearance of the hands and the satisfaction of the patient with the functionality of his hands. In the ladder pain, a high score indicates more intense pain, while in the rest of the items, a better score reveals better hand functionality. Duplicate filling time: 15 min (MHQ) 2 years
See also
  Status Clinical Trial Phase
Completed NCT01910116 - Efficacy of Shinabro in Hand Osteoarthritis Phase 2/Phase 3
Completed NCT02612233 - Pain Management in Osteoarthritis Using the Centrally Acting Analgesics Duloxetine and Pregabalin Phase 4
Completed NCT01249391 - Splinting to Treat Hand Osteoarthritis Phase 2
Recruiting NCT04402047 - Electroacupuncture vs Topical Diclofenac Sodium Gel for Patients With Hand Osteoarthritis N/A
Completed NCT03911570 - Crystalline Glucosamine Sulfate Therapy in Hand Osteoarthritis
Completed NCT04576403 - Heated Mittens for Patients With Hand Osteoarthritis N/A
Completed NCT02528630 - Progressive Strength in Hand Osteoarthritis Phase 4
Completed NCT01874067 - C-GLOVES: the Effectiveness of Compression Gloves in Arthritis
Suspended NCT03703934 - Central Pain Mechanisms in Patients With Hand-Osteoarthritis, Psoriatic Arthritis and Healthy Controls
Completed NCT04585113 - Diagnostic Accuracy of Dual-energy CT
Completed NCT05568875 - Happy Hands - an E-self-management Intervention for People With Hand Osteoarthritis N/A
Completed NCT03693833 - CBD Treatment in Hand Osteoarthritis and Psoriatic Arthritis. Phase 2
Completed NCT05150171 - Happy Hands E-self-management Pilot Study N/A
Completed NCT02667145 - Assistive Device for Hand Osteoarthritis N/A
Completed NCT02477059 - Effect of the Interleukin-6 Receptor Antagonist Tocilizumab in Patients With Hand Osteoarthritis Phase 3
Recruiting NCT04611347 - Topical CBD in Joint Arthritis Phase 2
Completed NCT04036929 - Can we Use Estrogen-containing Therapy to Improve Pain in Women After Menopause With Hand Osteoarthritis? N/A
Completed NCT03919279 - Treatment of Erosive Digital Osteoarthritis by Transcutaneous Auricular Nerve Stimulation N/A
Recruiting NCT06329219 - Water-filtered Infrared-A Radiation in Patients With Hand Osteoarthritis N/A
Not yet recruiting NCT05216757 - Efficacy and Safety of Iguratimod in Patients With Hand Osteoarthritis (ESIGO) Phase 2/Phase 3